LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,441 pages found matching data breach- St. Jude Battery Failure, Delayed Recall and it all comes down to Money
Sep-28-17 Santa Cruz, CA: The battery seems to have run out, so to speak, on St. Jude’s recall process. The company made a change to its battery design back in 2015 but didn’t acknowledge the reasoning behind the design—until the lithium battery defects were confirmed internally. The FDA finally initiated a Class I recall (the most seri... - Endo Facing Class Action over Opioid Marketing
Philadelphia, PA: A deceptive marketing class action lawsuit has been filed by the Philadelphia Federation of Teachers Health and Welfare Fund (PFTHWF) against Endo International PLC for allegedly fraudulently marketing its opioid painkiller as being safe and effective treatment for chronic pain. According to the proposed lawsuit, Endo, which mak... - Facebook Slapped with Disability and Age Discrimination Lawsuit with Whistleblower Allegation
Sep-27-17 Los Angeles, CA: A former Facebook employee, 52-year-old Gary Glouner, alleges in a lawsuit filed in California Superior Court that he was unlawfully terminated from his job in November, 2015. The suit alleges the company discriminated against him because of a minor cognitive disability and because he was not part of the company’s preferred demo... - FDA Warns of Continued High Death Rates with Syncardia Heart Transplant Devices
Washington, DC: The US Food and Drug Administration has issued an update to healthcare providers, informing them of the latest findings from the SynCardia TAH-t post-approval study. The results support earlier findings which show a continued higher three-month mortality rate for the subgroup of patients requiring pre-implant circulatory rescue in... - Attorney Files Equifax Class Action Lawsuit
Sep-25-17 San Jose, CA: In the wake of an Equifax data breach that occurred in July but reported this September, attorneys at Oakland, California- based Scott Cole & Associates have filed a lawsuit seeking class action status against the credit reporting agency. This digital disaster could potentially affect up to 175 million Americans, and millions of peopl... - Burn Pit Lawsuit Shows How Hard it is to Sue Military Contractors
Sep-25-17 Baltimore, MD: The US District Court’s dismissal of the multidistrict litigation, In re: KBR, Inc., Burn Pit Litigation is about more than Iraq and Afghanistan burn pits . The exhaustive opinion demonstrates why it is so hard for veterans and their families to sue military contractors when they are hurt because contractors fail to exercise ap... - Recent Monsanto Roundup Lawsuit Targets Alleged Marketing Violations
Sep-23-17 Madison, WI: The basket of Monsanto Roundup lawsuits has grown, with another class action launched June 20 of this year in Wisconsin ( Blitz et al. v. Monsanto Company et al. , Case No. 3:17-cv-00473, United States District Court, Western District of Wisconsin ). In this most recent claim, plaintiffs from Wisconsin, Illinois, California, New York, New... - Actemra: Failure to Warn
Sep-22-17 Washington, DC: Given the fact that Actemra is marketed without warning of heart failure, stroke, and other serious injuries like its competitors must do, one would think it is the wonder drug for rheumatoid arthritis sufferers. Until research and adverse event reports (AERS) got in the way and showed the med was just as likely to cause serious injurie... - Infusion Pumps, Medtronic SynchroMed Among Them, Remain Under Scrutiny
Sep-18-17 Washington, DC: The honeymoon the then-fresh Obama Administration was still largely enjoying in 2010 was nonetheless tainted two years into Barack Obama’s Presidency with revelations that hundreds of Americans supposedly had died due to malfunctioning infusion pumps. The Medtronic SynchroMed pump was among the plethora of infusion pumps that were com... - Sexual Dysfunction was Always There, but the Conversation Changed with Propecia
Sep-18-17 Washington, DC: When finasteride (Proscar) was first approved by the US Food and Drug Administration (FDA) as a treatment for benign prostatic hyperplasia (enlarged prostate) in 1992, researchers found higher incidents of sexual dysfunction in study participants taking finasteride when compared against a control group taking a placebo. Two dosages were... - Did Sanofi-Aventis Have a Duty to Warn Patients about Permanent Hair Loss?
Sep-12-17 Santa Clara, CA: As the litigation shakes out, that question is at the heart of Taxotere hair loss suits now pending in federal courts in Louisiana and other jurisdictions. But whether Sanofi-Aventis had a duty to warn patients is more complicated than it might appear. It requires courts to define what responsibility pharmaceutical companies have to th... - FDA Clears Bair Hugger for Post-Surgical Use
Sep-12-17 Washington, DC: 3M’s , Bair Hugger, the subject of some 2600 defective products lawsuits across the US, has received clearance for use from the US Food and Drug Administration (FDA). According to a spokesperson for the FDA, the agency has no conclusive evidence to establish an association between use of a forced air thermal regulating sy... - Risperdal Plaintiff Green Lighted to Pursue Risperdal Lawsuit in New York
Sep-11-17 New York, NY: The plaintiff in a Risperdal lawsuit who faced a petition for summary judgement on the part of the manufacturer, won the right to pursue the majority of his claims following a ruling by a New York judge that testimony by an expert witness is admissible, and may stand. According to Court documents plaintiff Jamal Adeghe was ten years of... - Equifax Data Breach Liability
Washington, DC: Equifax Inc, is facing several lawsuits over its recent and enormous data breach, which affects nearly half of the population in the US. One of the largest data breaches in US history, the credit reporting agency only revealed in September that hackers had accessed about 143 million US consumers’ names, Social Security numb... - Kohl TCPA Violations Lawsuit News and Legal Information
Kohl’s department store is facing allegations that it violates the Telephone Consumer Protection Act (TCPA) by using an automatic-capable dialer to send unsolicited text messages to plaintiffs and consumers nationwide, even after consumers have withdrawn their consent. Attorneys are investigating complaints of Kohl’s unsolicited messages and may seek to... - Despite Concerns over Onglyza, FDA Keeps Going Back to the Trough
Sep-6-17 Washington, DC: In the accepted parlance of the pharmaceutical and medical industries, a drug is considered not unsafe for the intended patient if the benefits of the drug outweigh the risk. One can therefore assume that the US Food and Drug Administration (FDA) took this mantra to heart in 2009 when the federal regulator approved Onglyza (saxagliptin) in... - Testosterone Lawsuits Begin, Outcomes Split
Sep-5-17 Chicago, IL: The makers of a testosterone supplement that only carries FDA approval for hypogonadism (severely depleted testosterone) but nonetheless has been heavily marketed to treat a largely manufactured disease, won their day in court at the end of last month when a jury in state court found in favor of AndroGel manufacturer AbbVie. The decision trans... - New Information Shown to Jury Produced Record Talc Verdict
Aug-30-17 Los Angeles, CA A jury trial in California recently ordered Johnson & Johnson to pay a record $417 million to a woman dying of ovarian cancer for failure to warn that the genital talc use could cause cancer. Eva Echeverria used J&J’s Johnson’s Baby Power on a daily basis for decades and claimed talc ultimately led to her cancer diag... - Zetia and Vytorin Continue to be Controversial
Aug-28-17 Washington, DC: There is little doubt that the cholesterol-fighting drug Zetia (ezetimibe) has travelled a rocky road since it was first approved by the US Food and Drug Administration (FDA) in 2002. And while several years have passed since the controversial delay in releasing study results into potential Zetia side effects , issues involving Zetia and... - Qui Tam Whistleblower Lawsuit Goes After “Up Coding”
Aug-28-17 Atlanta, GA: The Medical Center, Navicent Health (“Navicent”) has agreed to pay $2,549,742 to the United States and the State of Georgia to resolve allegations that it violated the federal False Claims Act (FCA) and the Georgia False Medicaid Claims Act by submitting inflated bills for ambulance transportation. The qui tam whistleblower lawsu...